resistant depression

THE SERTRALINE VERSUS ELECTRICAL CURRENT THERAPY for TREATING DEPRESSION CLINICAL STUDY (SELECT-TDCS): RESULTS of the CROSSOVER and FOLLOW-UP PHASES.

Published May 1, 2013

THE SERTRALINE VERSUS ELECTRICAL CURRENT THERAPY FOR TREATING DEPRESSION CLINICAL STUDY (SELECT-TDCS): RESULTS OF THE CROSSOVER AND FOLLOW-UP PHASES.

Depress Anxiety. 2013 Apr 26;
Valiengo L, Benseñor IM, Goulart AC, de Oliveira JF, Zanao TA, Boggio PS, Lotufo PA,… Continue reading →

Depression Not Sadness

Published April 30, 2013

Depression Not Sadness – The differences between clinical depression and sadness.

Patients, professionals say treatment is key to living with depression
Clinical depression goes well beyond temporarily feeling sad or blue. It affects ones thoughts, feelings and behavior.… Continue reading →

Migraine, Headache, and the Risk of Depression: Prospective Cohort Study.

Published April 17, 2013

Migraine, headache, and the risk of depression: Prospective cohort study.

Cephalalgia. 2013 Apr 15;
Rist PM, Schürks M, Buring JE, Kurth T

BACKGROUND: While cross-sectional studies have shown associations between migraine and depression, few studies have been able to… Continue reading →

The Lack of Association Between Components of Metabolic Syndrome and Treatment Resistance in Depression.

Published April 14, 2013

The lack of association between components of metabolic syndrome and treatment resistance in depression.

Psychopharmacology (Berl). 2013 Apr 12;
Sagud M, Mihaljevic-Peles A, Uzun S, Cusa BV, Kozumplik O, Kudlek-Mikulic S, Mustapic M, Barisic I, Muck-Seler D, Pivac N… Continue reading →

Molecular Aging of the Brain, Neuroplasticity, and Vulnerability to Depression and Other Brain-Related Disorders.

Published April 12, 2013

Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders.

Dialogues Clin Neurosci. 2013 Mar; 15(1): 53-65
Sibille E

The increased risk for neurodegenerative and neuropsychiatric disorders associated with extended lifespan has long suggested mechanistic… Continue reading →

Test-Retest Reliability of the Seasonal Pattern Assessment Questionnaire in Old Order Amish.

Published April 9, 2013

Test-retest reliability of the Seasonal Pattern Assessment Questionnaire in Old Order Amish.

Int J Disabil Hum Dev. 2013 Feb; 12(1): 87-90
Kuehner RM, Vaswani D, Raheja UK, Sleemi A, Yousufi H, Mohyuddin H, Postolache N, Nijjar GV, Postolache TT… Continue reading →

Impact of Family History in Persons With Dual Diagnosis.

Published March 30, 2013

Impact of Family History in Persons With Dual Diagnosis.

J Dual Diagn. 2013 Feb 13; 9(1): 30-38
Wilson CS, Bennett ME, Bellack AS

This study examined relationships among family history of alcohol, drug, and psychiatric problems and substance use… Continue reading →

Interaction of Neuropeptide Y Genotype and Childhood Emotional Maltreatment on Brain Activity During Emotional Processing.

Published March 15, 2013

Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing.

Soc Cogn Affect Neurosci. 2013 Mar 11;
Opmeer EM, Kortekaas R, van Tol MJ, van der Wee NJ, Woudstra S, van Buchem MA, Penninx… Continue reading →

Does the Revised Child Anxiety and Depression Scale (RCADS) Measure Anxiety Symptoms Consistently Across Adolescence? the TRAILS Study.

Published March 14, 2013

Does the Revised Child Anxiety and Depression Scale (RCADS) measure anxiety symptoms consistently across adolescence? The TRAILS study.

Int J Methods Psychiatr Res. 2013 Mar 11;
Mathyssek CM, Olino TM, Hartman CA, Ormel J, Verhulst FC, Van Oort FV… Continue reading →

How Is Smoking Weed for Depression Any Different Than Taking Antidepressants?

Published March 10, 2013

Question by Kyle Andrew: How is smoking weed for depression any different than taking antidepressants?
I always hear people talk about how smoking weed (or any drug for that matter) is pathetic, but then they go on to say “go… Continue reading →